BORRELIOSIS (LYME DISEAE) AND
RELAPSING FEVER
PRESENTOR: AKELLO MODESTUS FAITH
2021-08-07165
SUPERVISOR: DR. ABSHIR
OUTLINE
• Definition
• Epidemiology
• Transmission
• Pathogenesis
• Clinical presentation
• Diagnosis
• Management
LYME DISEASE.
• Lyme disease is a tick-borne disease caused by
species of Borrelia bacteria, transmitted to
humans by an infected blood-feeding ticks of
the genus Ixodes.
• 1977- first recognized clinically by Dr. Allen Steere
• 1980s- identification of Borrelia spirochete and tick
vector by Dr. Willy Burgdorfer
Borrelia species associated with
lyme disease include;
•B.burgdoferi most common
•B.garinii
•B.mayonii
•B.afzelii
•B.spielmanii
•B.valaisiana
Borrelia spp associated with relapsing fever
include
• B.recurrentis (most common)
• B.duttonii
• B.hermsii
• B.parkeri
• B.turicatae
EPIDEMIOLOGY.
• For some unknown reason, Lyme disease is
commonly reported in the Caucasians but can
infect all races.
• It affects people of all ages.
• Appears to be slightly more common in
females.
• B. burgdoferi is distributed in USA, Russia,
Europe, Japan, Australia and china.
• B. afzelli and B. garinii are additionally found in
Europe and Asia.
NOTE;
Borrelia spp are large motile spirochete with
irregular wide open coils.
Gram negative and stained with Giemsa stain.
B. recurrentis- relapsing fever
B burgdorferi – lyme disease
TRANSMISSION.
• Lyme disease is spread by primarily 4 Ixodes
species worldwide;
I. scapularis (the deer tick) in the north US
I. pacificus in the western US
I. ricinus in Europe
I. persulcatus in Asia
PATHOGENESIS.
• The bacteria enter the skin at the site of the tick
bite. After 3-32 days, the bacteria migrate
locally in the skin around the bite causing
inflammation at the site characterized by
erythema migrans.
• They then spread via lymphatics causing
regional lymphadenopathy.
Pathogenesis cont.
• Or disseminate in blood causing bacteremia
and affects other organs.
Significant antibody response to infection
occurs at this stage due to activation of the
immune system
CLINICAL PRESENTATION.
• There are 3 stages of the disease. Progression
may be arrested at any stage.
EARLY LOCALIZED DISEASE.(lasts days to
months)
Main feature is a skin reaction around the site of
bite, known as erythema migrans , occurs in 80%
of all cases.
Initially, a red “bull’s eye” rash appears 2-30 days
post bite and it centrally enlarges
• Additionally the EM rash may also be
accompanied by non specific symptoms like
fatigue, myalgia, malaise, fever, headache,
rash and regional lymphadenopathy.
EARLY DISSEMINATED DISEASE.
• Progression to this stage occurs in untreated
individuals weeks to months following the
initial tick bite.
Complications during this stage include;
• Neurological involvement: it classically
presents with the triad of
 lymphocytic meningitis
cranial nerve palsies
peripheral neuropathy.
• Radiculopathy which is often painful may
present a year or more after initial infection
• Carditis sometimes accompanied by
atrioventricular conduction defects may occur
Lyme disease is one of the most common
cause of second degree heart block.
LATE DISEASE
• Occurs months to years post bite
• Arthritis (affecting long bones), polyneuritis
and encephalopathy causing neuropsychiatric
abnormalities
• Acrodermatitis chronica atrophicans is a rare
late complication characterized by doughy,
patchy discoloration on the peripheries that
later leads to shiny atrophic skin.
DIAGNOSIS.
Diagnosis is clinical but the following investigations
can be done:
• Culture from biopsy is rarely available, has low yield
and may take over 6 weeks.
• Antibody detection is frequently negative in early
course.
• Immunoblot (western blot) techniques are more
specific and should be used.
• ELIZA used to confirm the diagnosis.
• PCR for detection of microorganisms DNA in blood,
CSF and biopsies from skin and synovium.
MANAGEMENT.
• Asymptomatic patients with positive antibody
tests do not require treatment. However,
erythema migrans always requires therapy even
when the skin lesions resolve.
• Standard therapy is a 14-day course of
doxycycline (200mg daily) or amoxicillin
(500mg 3 times daily).
2nd
line drugs
• Azithromycin 500mg for 5-10 days.
• Cefuroxime 500mg BD for 14 days.
• Cephalosporins can be used in severe disease.
Prognosis.
good outcome with treatment
Poor outcome as disease disseminates
Doxycycline is enough for the erythema
migrans.
RELAPSING FEVER.
Definition: Relapsing fever is a vector-borne disease
caused by bacteria Borrelia recurrentis
• Transmitted through the bites of lice, soft-bodied
ticks (genus Ornithodoros), or hard-bodied ticks
(Genus Ixodes).
Types of relapsing fever include:
Louse- borne relapsing fever
Tick borne relapsing fever
TRANSMISSION
Louse-borne relapsing fever.
• Louse –borne relapsing fever is spread from
person to person when the louse takes a
spirochete blood meal from an infected person.
• They then multiply in the lice body but are not
present in saliva
• Through human body louse (pediculus humanus),
B. recurrentis are released from the infected lice
thus inoculating Borreliae into the skin.
• The borreliea multiply rapidly in the blood during
febrile phases and invade most tissues especially
the liver, spleen and meninges.
EPIDEMIOLOGY: the disease occurs worldwide with
epidemics seen in Central, East and South Africa.
CLINICAL FEATURES
• Sudden onset of fever
• Temperature(39.5-40.5C)
• Headache
• Herpes labialis, generalised body aching and
• Injected conjunctivae.
• Thrombocytopenia associated with petichea rash
and epistasis.
In advanced disease:
• Tender hepatosplenomegaly, jaundice and elevated
transaminases
• Serosal and intestinal heamorrhages
• Delirium and menigism
The fever ends between 4th
and 10th
day associated
with profuse sweating, hypotension and cardiac
failure.
With out treatment the mortality rate is 40%especially
in malnourished and older patients.
Investigation and management.
• Do a ground microscopy of a wet film.
TREATMENT:
IM procaine penicillin 300mgs the followed by
500mg tetracycline.(effective and prevents
relapse) OR doxycycline 200mgs OD
Free the patients clothings from lice.
Improve patient’s nutrition status
Chloramphenicol and ceftriaxone can also be used
Tick- borne relapsing fever.
• Soft tick (Ornithodoros spp.) transmit B. duttoni
through saliva while feeding on their hosts.
• The spirochete pass into the ovary of the tick and
its off springs are automatically infected(vertical
transmission) and so is infectious for life.
• Rodents are the reservoirs except in East Africa
where the humans are the reservoirs.
People living in mud houses are at high risk.
Once a house has been infested, remains a danger for
many years if no intervention
Similar clinical manifestations to those of the
louse borne disease.
THOUGH a dark film microscopy may not detect
the micro organism in most patients.
TREATMENT
• A 7- day course Treatment with tetracycline
500mgs qid OR
• Erythromycin 500mgs qid
Jarisch-Herxheimer Reaction(JHR)
• Some deaths occur after starting treatment as a
result of Jarisch-Herxheimer reaction.
• Common in all spirochete infections.
• JHR results when the antibiotics suddenly kill a large
number of spirochetes which release toxins into the
blood causing the patient to collapse.(common with
large doses of broad spectrum antibiotics).
• JHR is characterized by a fall in blood pressures,
chills and rapid breathing.
• Patient must be nursed, given adequate fluids and
bed rest for at least 24hrs.
• To prevent JHR, use prednisolone 10-20mgs TDS
for 3 days then start treatment 24hrs later.
Prognosis: with antibiotic treatment, the mortality
rate decreases from (10%-40% to 2%-4%). Lower
rates in tick –borne than louse-borne relapsing
fever.
Differential diagnosis. (all infectious diseases)
• Malaria
• Leptospirosis
• Yellow fever
• Brucellosis
• Ehrilichiosis
References.
• Davidsons-principles-and-practice-of-
medicine-2022-pgs 304, 305.
• https://www.ncbi.nlm.gov/books
• Geneva E Guarin, MD, MBA Resident
physician, I MED, Einstein Medical Center
Philadelphia. (med scape)

BORRELIOSIS_(LYME_DISEAE) 4.2 class.pptx

  • 1.
    BORRELIOSIS (LYME DISEAE)AND RELAPSING FEVER PRESENTOR: AKELLO MODESTUS FAITH 2021-08-07165 SUPERVISOR: DR. ABSHIR
  • 2.
    OUTLINE • Definition • Epidemiology •Transmission • Pathogenesis • Clinical presentation • Diagnosis • Management
  • 3.
    LYME DISEASE. • Lymedisease is a tick-borne disease caused by species of Borrelia bacteria, transmitted to humans by an infected blood-feeding ticks of the genus Ixodes. • 1977- first recognized clinically by Dr. Allen Steere • 1980s- identification of Borrelia spirochete and tick vector by Dr. Willy Burgdorfer
  • 4.
    Borrelia species associatedwith lyme disease include; •B.burgdoferi most common •B.garinii •B.mayonii •B.afzelii •B.spielmanii •B.valaisiana
  • 5.
    Borrelia spp associatedwith relapsing fever include • B.recurrentis (most common) • B.duttonii • B.hermsii • B.parkeri • B.turicatae
  • 6.
    EPIDEMIOLOGY. • For someunknown reason, Lyme disease is commonly reported in the Caucasians but can infect all races. • It affects people of all ages. • Appears to be slightly more common in females. • B. burgdoferi is distributed in USA, Russia, Europe, Japan, Australia and china.
  • 7.
    • B. afzelliand B. garinii are additionally found in Europe and Asia. NOTE; Borrelia spp are large motile spirochete with irregular wide open coils. Gram negative and stained with Giemsa stain. B. recurrentis- relapsing fever B burgdorferi – lyme disease
  • 8.
    TRANSMISSION. • Lyme diseaseis spread by primarily 4 Ixodes species worldwide; I. scapularis (the deer tick) in the north US I. pacificus in the western US I. ricinus in Europe I. persulcatus in Asia
  • 9.
    PATHOGENESIS. • The bacteriaenter the skin at the site of the tick bite. After 3-32 days, the bacteria migrate locally in the skin around the bite causing inflammation at the site characterized by erythema migrans. • They then spread via lymphatics causing regional lymphadenopathy.
  • 10.
    Pathogenesis cont. • Ordisseminate in blood causing bacteremia and affects other organs. Significant antibody response to infection occurs at this stage due to activation of the immune system
  • 12.
    CLINICAL PRESENTATION. • Thereare 3 stages of the disease. Progression may be arrested at any stage. EARLY LOCALIZED DISEASE.(lasts days to months) Main feature is a skin reaction around the site of bite, known as erythema migrans , occurs in 80% of all cases. Initially, a red “bull’s eye” rash appears 2-30 days post bite and it centrally enlarges
  • 13.
    • Additionally theEM rash may also be accompanied by non specific symptoms like fatigue, myalgia, malaise, fever, headache, rash and regional lymphadenopathy.
  • 14.
    EARLY DISSEMINATED DISEASE. •Progression to this stage occurs in untreated individuals weeks to months following the initial tick bite. Complications during this stage include; • Neurological involvement: it classically presents with the triad of  lymphocytic meningitis cranial nerve palsies peripheral neuropathy.
  • 15.
    • Radiculopathy whichis often painful may present a year or more after initial infection • Carditis sometimes accompanied by atrioventricular conduction defects may occur Lyme disease is one of the most common cause of second degree heart block. LATE DISEASE • Occurs months to years post bite • Arthritis (affecting long bones), polyneuritis and encephalopathy causing neuropsychiatric abnormalities
  • 16.
    • Acrodermatitis chronicaatrophicans is a rare late complication characterized by doughy, patchy discoloration on the peripheries that later leads to shiny atrophic skin.
  • 17.
    DIAGNOSIS. Diagnosis is clinicalbut the following investigations can be done: • Culture from biopsy is rarely available, has low yield and may take over 6 weeks. • Antibody detection is frequently negative in early course. • Immunoblot (western blot) techniques are more specific and should be used. • ELIZA used to confirm the diagnosis. • PCR for detection of microorganisms DNA in blood, CSF and biopsies from skin and synovium.
  • 18.
    MANAGEMENT. • Asymptomatic patientswith positive antibody tests do not require treatment. However, erythema migrans always requires therapy even when the skin lesions resolve. • Standard therapy is a 14-day course of doxycycline (200mg daily) or amoxicillin (500mg 3 times daily).
  • 19.
    2nd line drugs • Azithromycin500mg for 5-10 days. • Cefuroxime 500mg BD for 14 days. • Cephalosporins can be used in severe disease. Prognosis. good outcome with treatment Poor outcome as disease disseminates Doxycycline is enough for the erythema migrans.
  • 20.
    RELAPSING FEVER. Definition: Relapsingfever is a vector-borne disease caused by bacteria Borrelia recurrentis • Transmitted through the bites of lice, soft-bodied ticks (genus Ornithodoros), or hard-bodied ticks (Genus Ixodes). Types of relapsing fever include: Louse- borne relapsing fever Tick borne relapsing fever
  • 21.
    TRANSMISSION Louse-borne relapsing fever. •Louse –borne relapsing fever is spread from person to person when the louse takes a spirochete blood meal from an infected person. • They then multiply in the lice body but are not present in saliva • Through human body louse (pediculus humanus), B. recurrentis are released from the infected lice thus inoculating Borreliae into the skin.
  • 22.
    • The borrelieamultiply rapidly in the blood during febrile phases and invade most tissues especially the liver, spleen and meninges. EPIDEMIOLOGY: the disease occurs worldwide with epidemics seen in Central, East and South Africa. CLINICAL FEATURES • Sudden onset of fever • Temperature(39.5-40.5C) • Headache • Herpes labialis, generalised body aching and • Injected conjunctivae.
  • 23.
    • Thrombocytopenia associatedwith petichea rash and epistasis. In advanced disease: • Tender hepatosplenomegaly, jaundice and elevated transaminases • Serosal and intestinal heamorrhages • Delirium and menigism The fever ends between 4th and 10th day associated with profuse sweating, hypotension and cardiac failure. With out treatment the mortality rate is 40%especially in malnourished and older patients.
  • 24.
    Investigation and management. •Do a ground microscopy of a wet film. TREATMENT: IM procaine penicillin 300mgs the followed by 500mg tetracycline.(effective and prevents relapse) OR doxycycline 200mgs OD Free the patients clothings from lice. Improve patient’s nutrition status Chloramphenicol and ceftriaxone can also be used
  • 25.
    Tick- borne relapsingfever. • Soft tick (Ornithodoros spp.) transmit B. duttoni through saliva while feeding on their hosts. • The spirochete pass into the ovary of the tick and its off springs are automatically infected(vertical transmission) and so is infectious for life. • Rodents are the reservoirs except in East Africa where the humans are the reservoirs. People living in mud houses are at high risk. Once a house has been infested, remains a danger for many years if no intervention
  • 26.
    Similar clinical manifestationsto those of the louse borne disease. THOUGH a dark film microscopy may not detect the micro organism in most patients. TREATMENT • A 7- day course Treatment with tetracycline 500mgs qid OR • Erythromycin 500mgs qid
  • 27.
    Jarisch-Herxheimer Reaction(JHR) • Somedeaths occur after starting treatment as a result of Jarisch-Herxheimer reaction. • Common in all spirochete infections. • JHR results when the antibiotics suddenly kill a large number of spirochetes which release toxins into the blood causing the patient to collapse.(common with large doses of broad spectrum antibiotics). • JHR is characterized by a fall in blood pressures, chills and rapid breathing. • Patient must be nursed, given adequate fluids and bed rest for at least 24hrs.
  • 28.
    • To preventJHR, use prednisolone 10-20mgs TDS for 3 days then start treatment 24hrs later. Prognosis: with antibiotic treatment, the mortality rate decreases from (10%-40% to 2%-4%). Lower rates in tick –borne than louse-borne relapsing fever. Differential diagnosis. (all infectious diseases) • Malaria • Leptospirosis • Yellow fever • Brucellosis • Ehrilichiosis
  • 29.
    References. • Davidsons-principles-and-practice-of- medicine-2022-pgs 304,305. • https://www.ncbi.nlm.gov/books • Geneva E Guarin, MD, MBA Resident physician, I MED, Einstein Medical Center Philadelphia. (med scape)